Acquisition de matrices biologiques humaines pour la fabrication de matériaux de contrôle interlaboratoires

Description: INSPQ intends to enter a sole-source, on-demand supply contract with BioIVT for human EDTA-anticoagulated whole blood and human serum for the Centre de toxicologie du Québec’s laboratory activities. The materials will support interlaboratory control materials, analytical-method development and validation, and specialized analyses, with requirements for documented handling, lot traceability, controlled cold-chain handling, and viral testing. Businesses offering equivalent products may submit documented expressions of interest showing technical compliance and compatibility with CTQ methods by the stated deadline.